Unibest
← Back to patent-cliff list

CAS 1443531-67-6

4-amino-5-(7-methoxy-5-methylbenzo[b]thiophen-2-yl)-6-(methoxymethyl)pyrrolo[2,1-f][1,2,4]triazine-7-carbaldehyde

Codes: ROGAR-008

Application context (from source-drug indications)

SarcomaRogaratinibGastrointestinal stromal tumourRogaratinibBreast cancerRogaratinibMetastatic breast cancerRogaratinibNon-small cell lung cancerRogaratinibUrothelial carcinomaRogaratinib

Source drugs (routes using this intermediate)

DrugTierExpiry
RogaratinibTier C — Watch / trade-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

Intermediates available on this site

No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.